A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed ; volume:10 ; number:3 ; year:2017 ; pages:1065-1069
Case reports in oncology ; 10, Heft 3 (2017), 1065-1069
- Creator
-
Natsume, Maika
Honda, Takeshi
Haruyama, Terunobu
Ishihara, Masashi
Fukasawa, Yoko
Sakamoto, Takahiko
Tanzawa, Shigeru
Usui, Ryo
Ota, Shuji
Ichikawa, Yasuko
Watanabe, Kiyotaka
Seki, Nobuhiko
- DOI
-
10.1159/000484662
- URN
-
urn:nbn:de:101:1-2018053112462241973906
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Natsume, Maika
- Honda, Takeshi
- Haruyama, Terunobu
- Ishihara, Masashi
- Fukasawa, Yoko
- Sakamoto, Takahiko
- Tanzawa, Shigeru
- Usui, Ryo
- Ota, Shuji
- Ichikawa, Yasuko
- Watanabe, Kiyotaka
- Seki, Nobuhiko
Other Objects (12)
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma
The marked huntress
Noncommutative marked surfaces
Noncommutative Marked Surfaces
Peritoneal carcinomatosis and malignant ascites
ED diagnosis of peritoneal carcinomatosis
CT mimics of peritoneal carcinomatosis
Meningeal carcinomatosis: three case-reports
Marked Space – Unmarked Space
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma
The marked huntress
Noncommutative marked surfaces
Noncommutative Marked Surfaces
Peritoneal carcinomatosis and malignant ascites
ED diagnosis of peritoneal carcinomatosis
CT mimics of peritoneal carcinomatosis
Meningeal carcinomatosis: three case-reports
Marked Space – Unmarked Space
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma
The marked huntress
Noncommutative marked surfaces
Noncommutative Marked Surfaces
Peritoneal carcinomatosis and malignant ascites
ED diagnosis of peritoneal carcinomatosis
CT mimics of peritoneal carcinomatosis
Meningeal carcinomatosis: three case-reports